The global biobanks market size is expected to reach USD 106.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2021 to 2028. Biobanks continue to evolve with the introduction of new technologies such as NGS and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market.
The quality of biospecimens can significantly influence the disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples. For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples.
This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.
Request a free sample copy or view report summary: Biobanks Market Report
The biobanking equipment segment accounted for the maximum revenue share in 2020 owing to the high cost of instruments coupled with an increase in the number of biorepositories
The biobanking and repository services segment accounted for the largest revenue share of 36.0% in the market
This is because of the higher penetration of these services and the increased need for the preservation of biosamples for developing precision medicine and disease-specific research
Human tissues are the most stored sample for clinical research, resulting in the dominance of this sample type in the market
The virtual biobanks segment is anticipated to witness the fastest growth rate over the forecast period owing to the growing demand for 3D biospecimens coupled with the need for rare disease data for biomedical research
The therapeutics application segment accounted for the largest revenue share in 2020 owing to the growing popularity of cell therapies for cancer treatment
Several pharma/biotech companies have established their private banks to support clinical trials and the development of cell therapies, resulting in revenue growth in this segment
North America dominated the market with its wide network of centers for biosample storage in the U.S.
Moreover, a high number of COVID-19 cases in the U.S. and increased R&D programs have resulted in the establishment of new biorepositories, thereby driving the revenue in North America
In Asia Pacific, the market is anticipated to register the fastest growth owing to the ever-expanding pharmaceuticals and clinical research domain across the Asian countries
The key players are engaged in expanding their global reach by partnering with global distributors, merger, and acquisition of other players, and entering a strategic alliance with research communities
Grand View Research has segmented the global biobanks market on the basis of product, service, biospecimen type, biobanks type, application, and region:
Biobanks Product Outlook (Revenue, USD Million, 2017 - 2028)
Temperature Control Systems
Freezers & Refrigerators
Cryogenic Storage Systems
Incubators & Centrifuges
Alarms & Monitoring Systems
Accessories & Other Equipment
Laboratory Information Management Systems
Biobanks Service Outlook (Revenue, USD Million, 2017 - 2028)
Biobanking & Repository
Cold Chain Logistics
Biobanks Biospecimen Type Outlook (Revenue, USD Million, 2017 - 2028)
Adult Stem Cells
Embryonic Stem Cells
Other Stem Cells
Biobanks Type Outlook (Revenue, USD Million, 2017 - 2028)
Population Based Biobanks
Disease Based Biobanks
Biobanks Application Outlook (Revenue, USD Million, 2017 - 2028)
Drug Discovery & Clinical Research
Biobanks Regional Outlook (Revenue, USD Million, 2017 - 2028)
Middle East & Africa
List of Key Players of Biobanks Market
Thermo Fisher Scientific, Inc.
Tecan Trading AG.
Becton, Dickinson and Company (BD)
Charles River Laboratories
STEMCELL Technologies Inc.
Precision Cellular Storage Ltd. (Virgin Health Bank)
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
Avail customized purchase options to meet your research needs:
"The quality of research they have done for us has been excellent..."